Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion type Assertion NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_head.
- NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion description "[The intravenous administration of an adenoviral encoding Fstl1 to mice resulted in a 66.0% reduction in myocardial infarct size after ischemia/reperfusion injury that was accompanied by a 70.9% reduction in apoptosis in the heart (P<0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_provenance.
- NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion evidence source_evidence_literature NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_provenance.
- NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion SIO_000772 18519848 NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_provenance.
- NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion wasDerivedFrom befree-20140225 NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_provenance.
- NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_assertion wasGeneratedBy ECO_0000203 NP349826.RAfkjkquK5tIF1UG2tc6cltuZnOtBSB2RX1zyuyc6jgYE130_provenance.